Journal article
Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice
The Journal of clinical investigation, Vol.118(11), pp.3588-3597
11/03/2008
DOI: 10.1172/JCI35847
PMCID: PMC2556240
PMID: 18830415
Abstract
Histone deacetylase (HDAC) inhibitors show remarkable therapeutic potential for a variety of disorders, including cancer, neurological disease, and cardiac hypertrophy. However, the specific HDAC isoforms that mediate their actions are unclear, as are the physiological and pathological functions of individual HDACs in vivo. To explore the role of Hdac3 in the heart, we generated mice with a conditional
Hdac3
null allele. Although global deletion of
Hdac3
resulted in lethality by E9.5, mice with a cardiac-specific deletion of
Hdac3
survived until 3–4 months of age. At this time, they showed massive cardiac hypertrophy and upregulation of genes associated with fatty acid uptake, fatty acid oxidation, and electron transport/oxidative phosphorylation accompanied by fatty acid–induced myocardial lipid accumulation and elevated triglyceride levels. These abnormalities in cardiac metabolism can be attributed to excessive activity of the nuclear receptor PPARα. The phenotype associated with cardiac-specific
Hdac3
gene deletion differs from that of all other
Hdac
gene mutations. These findings reveal a unique role for Hdac3 in maintenance of cardiac function and regulation of myocardial energy metabolism.
Details
- Title: Subtitle
- Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice
- Creators
- Rusty L Montgomery - Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USAMatthew J Potthoff - Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USAMichael Haberland - Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USAXiaoxia Qi - Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USASatoshi Matsuzaki - Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USAKenneth M Humphries - Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USAJames A Richardson - Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USARhonda Bassel-Duby - Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USAEric N Olson - Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
- Resource Type
- Journal article
- Publication Details
- The Journal of clinical investigation, Vol.118(11), pp.3588-3597
- DOI
- 10.1172/JCI35847
- PMID
- 18830415
- PMCID
- PMC2556240
- NLM abbreviation
- J Clin Invest
- ISSN
- 0021-9738
- eISSN
- 1558-8238
- Publisher
- American Society for Clinical Investigation
- Language
- English
- Date published
- 11/03/2008
- Academic Unit
- Iowa Neuroscience Institute; Neuroscience and Pharmacology
- Record Identifier
- 9984040210602771
Metrics
14 Record Views